It is known that convulsive therapy was introduced by Meduna for schizophrenia without a thought of what later became its most extensive area of application. The theory that schizophrenia and epilepsy exclude each other, and some clinical observations on the removal of psychotic syndromes, led to the discovery of convulsive therapy, and it was not until several years later that its usefulness in depressions was recognized. This is not the place to discuss technical problems of convulsive therapy. This presentation will primarily deal with the electric form of convulsive therapy. Pharmacological convulsive therapy with pentamethylenetetrazol has not entirely been abandoned, and has even found a revival in certain schizophrenic conditions where it seems to be slightly superior to ECT; but this superiority has never been claimed for depressions. A newer modification of convulsive therapy, the induction of convulsions by means of the inhalant "Indoklon" offers interesting possibilities, but its indications do not differ from those of other types of convulsive therapy. It is, therefore, justified to limit the discussion of convulsive therapy of depressions to ECT.
The various affective psychoses or endogenous depressive states respond equally well to RCT. The claim for a specific effect of any treatment in psychiatry is usually avoided, but nothing comes closer to a specific effect than the response of a typical depression to a predictable number of three or four electric shock treatments. It is the accepted procedure to give a few additional treatments to prevent a relapse, but it is hardly necessary to give more than six or eight treatments in the majority of cases, and results of close to 90 to 100 per cent have been reported by some workers when they limited their statistics to pure cases of affective psychoses. The rare occurrence of relapses is quite contrary to what we see in depressive syndromes of schizophrenia and some other psychotic syndromes associated with depression, as will be discussed later. The effect of ECT is limited to the depressive episode as such and does not influence in any way the course of the illness as, for example, the occurrence of future episodes. This is particularly true for the first group of depressions we are dealing with, the depressive phase of a manic-depressive psychosis. If these patients are treated "Attending Psychiatrist, New York State Psychiatric Institute, New York.
with ECT depressive episodes occur as often as they would without ECT. It will be discussed later in more detail that the shifting from a depressive to a manic episode which occurs after spontaneous remissions is also seen after ECT remissions. I t is surprising that this is not prevented by ECT in spite of the fact that the manic phase also can be treated successfully with convulsive methods, although treatment has to be more intense. Long-term follow-ups do not show any difference between ECT-treated and untreated depressions of a manic-depressive patient. Yet the possibility of shortening a depressive episode at will and the removal of the great suicidal risk are forceful arguments in favor of ECT. Also it must not be overlooked that the suicidal risk is more severe in the beginning of a depression than in the clearing-up phase. It is an old clinical experience that during the height of a depression when the patient is severely retarded and deprived of all his initiative, including self-destructive impulses, suicides are rare. This must be considered in weighing the decision between ECT and antidepressant drugs. It will depend on the clinical judgment of the therapist how seriously he considers the patient threatened by suicide. While I myself consider Tofranil* an extremely valuable addition to our therapeutic armamentarium, the suicidal risk frequently swings my decision toward immediate ECT. Social aspects such as the quicker and more reliable response of depressions to ECT also work in favor of a greater application of ECT than would be expected after the introduction of various antidepressant drugs. Acquaintance with the work in hospitals, particularly psychiatric wards in general hospitals, reveals that in this type of psychiatric facility drugs are not given much of a chance because of financial considerations. The predictability of the time required for the five or six electric shock treatments necessary in a depression, and on the other hand the uncertainty of the response to drugs, make it difficult to submit a patient who must pay for his hospital stay to pharmacotherapy which in many cases must still be followed by ECT. Perhaps this is not justified in view of the relatively quick response to Tofranil when it works at all. There is some evidence that the number of ECT's can be reduced after pharmacotherapy. W. Schmitt showed that as few as one or two convulsive treatments after an unconvincing result with Tofranil alone could lead to the desired therapeutic effect. ECT was usually given only after three to six weeks of medication. Such experiences diminish the hope that ECT can be given up as the best predictable treatment in all depressions. ECT clears up agitated and retarded depressions alike, whereas the effect of Tofranil seems to be limited to the non-agitated type of depression. The simultaneous treatment with Tofranil and ECT, which we ourselves were reluctant to use so far, has been applied by an increasing number of psychiatrists without untoward side effects or complications. We doubt, however, whether a reduction in the number of RCT's would justify a prolongation of the total treatment time of a depression. However, we do make increasing use of Tofranil after the actual symptoms of a depression begin to disappear, which is usually the case after three or four treatments. In patients who have a tendency to an early relapse, as is particularly true for some atypical depressions, we follow up ECT with Tofranil, and in this way reduce the rather large number of shock treatments necessary in such patients. A few patients who had been observed during previous depressions, and in a new depression were treated unsuccessfully with Tofranil, recovered with a smaller number of electric shock treatments than during their preceding episodes.
There seems to be a basic difference in the way pharmacotherapy and ECT work in depressions. Many workers who are using Tofranil, including myself, found that most patients responding to Tofranil after a few days must be kept under this medication for a considerable length of time. In some patients with a history of 'Trade Mark. S140 CANADIAN PSYCHIATRIC ASSOCIATION JOURNAL Vol. 4,1959 previous untreated depressions of known duration, it appears that medication with Tofranil is necessary almost as long as the depression usually lasted in these particular patients. This would mean that Tofraniflifts the depressive mood in a purely symptomatic fashion, while ECT removes the depression radically as far as the individual episode is concerned. If these observations are confirmed they would favor a continuation of ECT as the treatment of choice in the more serious depressrons, I t is obviously not right to call the effect of ECT in depressions simply symptomatic. Neither can it be proven that it is a specific treatment of the cause of the illness. We agree with Von Baeyer that we must distinguish between a therapeutic effect tied to the time of the treatment and one which lasts beyond the actual treatment. Depressions and other psychoses can disappear temporarily for the duration of the organic changes caused by the convulsive treatments. Electroencephalographic changes can last for one or several weeks, and may persist even when the psychopathological changes of confusion or memory impairment are no longer noticeable. They are expressions of an effect on the brain, and the question arises whether this brain disturbance suppresses the psychotic syndrome of depression or other disorder. An improvement limited more or less to this period of disturbed brain function is quite similar to the effect of a drug which covers up symptoms as long as the blood level of the drug is high enough, but does not act beyond this period. If, however, as is the case in the majority of depressions treated with ECT, the therapeutic effect remains beyond the period of disturbed brain function (in other words, longer than the effect of shock treatment in a nondepressive, healthy individual) we are justified in speaking of a specific or curative effect of electroconvulsive therapy.
Another question that needs clarification is whether a depression as a psychopathological manifestation requires psychotherapy to avoid recurrence after discontinuation of shock therapy. Statements have been made frequently that psychotherapy is indispensable, but these can be easily disproven. It has been said already that amnesia, in the sense of forgetting the experiences which presumably led to the depression, cannot serve as an explanation for the shock effect. Neither can it be said that ECT works in the same way as Klaesi's sleep treatment or the older opium treatment in depressions. These methods could be explained as means to give the patient complete emotional rest, and in a certain way to give him a new start. This rest could also be a factor in the treatment with neuroplegic drugs and their explanation as hibernation treatment. This test, also stressed in the Pavlovian concepts of Russian psychiatry, is certainly not present in ECT. Moreover, ECT cannot be called a form of psychotherapy, and the need for psychotherapy after ECT is also unproven.
Another point of both theoretical and practical importance is to what extent manic episodes do not simply follow, but are actually elicited by, the various treatment procedures. ECTvery frequently leads to a slight hypomanic state immediately after the treatment. This is of little practical importance and can be interpreted as a short-lasting organic reaction due to the ECT rather than a manic phase of the manic-depressive psychosis. True manic episodes immediately following ECT are extremely rare in my observation. Contrary to this, medication with iproniazid produced manic episodes more often. Such observations have already been reported for Tofranil too, but they seem to be less frequent than they were with iproniazid. Their occurrence must be taken into consideration when discussing means to prevent future depressive episodes. It is known that since the work of Geoghegan and Stevenson in Canada, preventive ECT for recurrent depressions has become a widely accepted procedure. It is likewise effective in preventing the manic as well as the depressive episodes of a manic-depressive patient. Such monthly and later bimonthly treatments, also recommended by Cameron, will be reserved for patients with very frequent episodes. While an acute manic episode responds less readily to ECT than a depression, and therefore will nowadays be treated particularly in hospitalized patients with neuroplegic drugs, the preventive value ofECT for manic episodes is at least as successful as that for depressions. In our experience such preventive ECT in manic-depressive patients could not yet be replaced by pharmacotherapy, because neuroplegic drugs after a manic episode often have a depressive effect, and the danger of manic reactions under antidepressant drugs diminishes the preventive value of these drugs after a depressive episode. In any event it is difficult to decide which of the two pharmacotherapeutic groups of drugs should be applied as a means of prevention in a patient tending to both depressive and manic reactions.
The response to ECT is of great interest in the question whether there is a difference between cyclothymic and reactive depressions. Our experience supports the view that many so-called reactive or neurotic depressions are actually cyclothymic depressions in the sense of the affective psychoses, but occurring in patients who also have certain neurotic features. There is a minority of such patients in whom depressive symptoms occur only as a response to adverse circumstances. They do not show the loss of weight seen so regularly in psychotic depressions, and also the sleep disturbances are less pronounced than they are in endogenous depressions. These patients have more often difficulty in falling asleep, while psychotic depressive patients, if they sleep at all, are more apt to wake up early. The poor response to ECT of this latter group of true reactive depressions may be of diagnostic significance and of some importance for the differentiation of depressions in general.
The favorable results of ECT are equally convincing in involutional melancholia, which is probably not a different type of sickness but the same affective psychosis occurring in a certain age group. The immediate response to ECT is an even more important factor in this group, because involutional depressions can persist much longer than manic-depressive depressions. As in all somatic treatments in psychiatry we only support the natural healing tendencies of the organism, but the value of the treatment is well illustrated by the observation that an involutional melancholia, though it may have lasted already a year or two, can be cured by electroshock with the same number of treatments (six or eight) as any short-lasting depression.
Before we speak about the failures in the two groups discussed so far, it may be mentioned that old-age depressions have the same chance of recovering under ECT as depressions in the other age groups. Many workers reported on the reliable and innocuous applicability of ECT in old-age depressions, and particularly reports by Roth and other English workers showed how many psychoses of old age are actually functional psychoses wrongly diagnosed as senile dementia. In such patients careful anamnesis often reveals one or two previous depressions many decades prior to the old-age depression.
So far the picture has been most favorable regarding the response to ECT in typical depressions. This must be followed by a detailed discussion of failures. The present era of the new antidepressant drugs makes this imperative. My personal experience with the first antidepressant drug iproniazid was that this drug was more helpful in the type of depression not responding to ECT ,than in uncomplicated affective psychoses.
Although I no longer use iproniazid because of the serious liver complications, I was impressed by the fact that a number of chronic and atypical depressions, in which ECT had never helped for more than a few weeks, responded very well to iproniazid. Even though some of these patients tended to become manic, these CANADIAN PSYCHIATRIC ASS0CIATIOr-i JOURNAL Vol. 4,1959 manic symptoms could be counteracted by neuroplegic drugs. The superiority of pharmacotherapy over ECT in some of these atypical depressions is undeniable. I have no personal opinion yet as to what extent Tofranil has the same value in those depressions refractory to ECT. This question must be further clarified on the basis of more psychopathological reports on individual cases if we want to come to a clearer understanding as to when pharmacotherapy is indicated and when ECT.
Depression is a frequent symptom in schizophrenia, and it is therefore not surprising that particularly in younger patients a depressive syndrome is often the predominant symptom of an underlying schizophrenic psychosis. This is best demonstrated by experiences we all have that when a patient with a moderate depression without deep affect is subjected to ECT, he develops a fullblown hallucinatory picture after the first treatment. It is obvious that such a syndrome after the first treatment is not an organic reaction to ECT but the appearance of a real schizophrenic psychosis whose depressive overlay was removed by one electrically induced convulsion. This observation led Halpern to the formulation that ECT may be an aid in the diagnosis of schizophrenia. It also happens most frequently that schizophrenic patients in whom a depression without deep affect seems to be the only symptom respond to a few electric shock treatments but relapse within a week after discontinuation of treatment, an occurrence so often seen in all types of schizophrenics. Further observation of such patients, whose first diagnosis is frequently manic-depressive psychosis, reveals very often that their depression was actually the first symptom of a schizophrenic psychosis and their prognosis was quite different from the favorable outlook in a manic-depressive psychosis. It is in these schizophrenic depressions that insulin coma treatment, possibly combined with some convulsive therapy, is most effective, and it has not been shown convincingly that pharmacotherapy can replace the shock treatments in these cases.
Post-partum depressions fall into this category of depressions with a shallower depressive affect and correspondingly less convincing response to ECT. While they do not have the ominous prognosis of many schizophrenic psychoses beginning with a depression, they have a clear tendency to relapse, and it is here that I find the use of Tofranil especially valuable in the prevention of relapse after a certain number of ECT's.
Failures with ECT hardly occur in typical cases of involutional melancholia. They are all the more frequent, however, in patients whose depression is complicated by other symptoms such as somatic delusions and hypochondriasis, and the same poor response to ECT is often seen in involutional depressions associated with paranoid symptoms. These cases of involutional psychosis which are not of purely paranoid type but are classified as mixed type are obviously schizophrenic psychoses occurring at a later age. They need much more extensive convulsive therapy and have a considerably less favorable prognosis even with such intensive treatment than cases of involutional melancholia. In these cases regressive ECT or the combination of sleep treatment and regressive ECT, as described by Cameron and Pende in chronic paranoid schizophrenics, should be promising. There is no reason to believe that the older age of these patients prevents them from receiving this combined sleep-regressive shock treatment. Regressive shock therapy with several treatments a day but not associated with sleep treatment has been applied by me in many such cases with results that were superior to regular ECT. This includes a number of patients in whom pharmacotherapy had been tried because of previous failure with regular ECT. This is the place to discuss a type of chronic depression that occurs in middle age or later and which was not recognized in the psychiatric literature until the introduction of ECT. Every psychiatrist experienced in this treatment is appalled by the resistance of these chronic depressions to ECT. Patients never fail to respond Special Supplement DEPRESSION AND ALLIED STATES S143 to a few treatments but they rarely reach a complete freedom from symptoms.
If their recovery is incomplete it is only a question of time until the same depressive symptoms recur, and the patient must be treated again. There is reason to believe that these patients have late schizophrenia rather than affective psychoses. I still find it indicated to try ECT in these cases but I immediately place them under Tofranil if they are known to have a tendency to relapse. Follow-up of patients in this group is too short to draw conclusions, and in some of these cases I had to apply ECT again in spite of medication with Tofranil.
Depression as a symptom of certain organic diseases of the central nervous system is not rare. Iri general paresis, depressive mood was more frequent than the much-quoted manic symptomatology. Such depressions cleared up under ECT, and this often made the etiological treatment of the disease by means of penicillin or malaria possible in a general hospital where otherwise such patients could not be kept. In arteriosclerotic or, less frequently, senile brain disease depressive symptoms may also occur, and these respond well to ECT. Here ECT is replaced by antidepressant drugs because the depressive affect or organic basis is usually not very deep, or the arteriosclerotic or senile patient may be simply depressed because he realizes his general decline. Depressed mood in epileptics either as a paroxysmal or a more lasting mood disturbance may be occasionally an indication for one or more convulsive treatments. Brain tumors have been sometimes overlooked, when a patient with previous depressions reacted to the cerebral pathology again with a depressive symptomatology. ECT is contraindicated in such patients, while Tofranil might have a good symptomatic effect. Experience shows that the symptom of depression responds equally well in organic and functional depressions to presentday treatments, but more material must be gathered before the question of pharmacotherapy versus ECT can be settled in this group.
The other organic, non-drug treatments have found very little application in depressions. It ha-s always been taken for granted that insulin coma treatment is not indicated in depressions. There is some evidence that this is not quite correct, but in the beginning of the insulin era schizophrenia was considered the only indication for this treatment, and later convulsive therapy as a much shorter and less expensive therapy turned out to be a spectacular success in depressions. Some workers who tried insulin had fair results but it never became widely used. Many other treatment procedures were only introduced to be discarded again for one reason or another. Only carbon dioxide treatment has been tried more extensively for a while. Its realm was various neurotic syndromes, and although depressive symptoms in such patients were secondary, they improved in some instances together with the neurotic symptoms.
Some comments are in order regarding psychosurgery in connection with depressions. Frontal lobe surgery, unfortunately discarded prematurely after the introduction of the neuroplegic drugs, is again being considered an important tool in psychiatric therapy but underwent considerable changes in its indications. In schizophrenia the emphasis shifted more and more from chronic deteriorated patients to those non-deteriorating schizophrenics with primarily paranoid or pseudoneurotic symptomatology often associated with depression. Pure depressions in the sense of the affective psychoses were not considered an indication for such surgical procedure. Contrary to Walter Freeman, who preferred lobotomy especially in its transorbital modification to repeated series of ECT, most psychiatrists felt that ECT, even if it must be repeated quite often, does not have any permanent side effects, while frontal lobe surgery often has. Another significant argument against psychosurgery was the observation that the deep depressive affect which characterizes psychotic depressions is the one emotional condition that is not influenced by frontal lobe surgery. While it is obvious that patients lacking emo-tional response -for example hebephrenics -cannot benefit from psychosurgery, it is less clear why patients with the severest emotional suffering, as represented by depressions, should not have the same benefit as many other groups of patients whose suffering, whether caused by physical or emotional sickness, was greatly relieved by surgical reduction of fronto-thalamic pathways. Contrary to other aggressive behavior, self-destructive tendencies remained unaltered and the literature shows a number of suicides committed in spite of frontal lobe surgery. More recent reports, however, seem to indicate that certain depressions may be an indication for psychosurgery. Recent follow-ups in England, either published or to be published, show convincingly what some of us have seen also in individual cases, namely that patients with chronic depressions may be excellent candidates for psychosurgery. This concerns mainly those chronic depressions of the older age group in whom somatic delusions, hypochondriacal symptoms and other atypical features accompany a depression, and where ECT has only a temporary and unconvincing therapeutic effect, or none at all. It seems that in these patients the basic symptoms are those we are inclined to consider a secondary admixture to the depression, but which are probably the primary symptoms on which some depression is superimposed. In this group pharmacotherapy will be tried but is often not the answer because too many different symptoms occur requiring different medication, and also because these patients are often quite sensitive to side effects of the drugs, and side effects are particularly disturbing to them.
Our own experience is mostly limited to operations in this type of patient with a mixed symptomatology which includes depression. The recent English reports by McKissack, Partridge and Elithorn show that typical depressions respond equally well. Elithorn even found, against our expectations, that endogenous depressions seem to respond more convincingly than reactive depressions. This conclusion was based not only on the impression of the investigator but also on statements the patient himself made when asked whether he was glad or whether he regretted having had the operation. Of the patients with endogenous depressions, 84 per cent answered that they we-e glad to have had the operation.
A group of patients in whom depression can be a very troublesome symptom for long stretches is represented by pseudoneurotic schizophrenics, who have been shown by Hoch and his co-workers to be particularly good candidates for psychosurgery. The basic symptom of these patients is pan-anxiety, and the psychodynamics of their superimposed depressions are not quite clear. Considerable experience with psychosurgery in these patients shows that once their basic symptoms are removed, the temporary depressive reactions no longer occur. It has been mentioned before that ECT can easily remove the depressive overlay in these pseudo-neurotic schizophrenics, but it never touches the main symptomatology in any lasting way.
The various comments made on the somatic treatments in depressions show how difficult and yet how significant the proper indications for the various treatments have become in recent years. They also show to what extent the psychopathology of an individual case must be studied before the therapist can arrive at the proper decision as to which of the various treatments available to us today is indicated. I resist the temptation to speculate how far the varying therapeutic response of different types of depressions to different treatments increases our understanding of the psychopathology of depressions. It is true that our hopes of coming to a better understanding of psychopathology through our growing ability to influence psychopathological phenomena at will remain unfulfilled. However, the material presenting itself to those interested in the observation of individual cases rather than of large groups of patients is so ample that it must some day improve our understanding of the diseases and symptoms we are treating. This is one goal that should never be lost sight of in our therapeutic work. The most important practical conclusion which, I hope, will be drawn from this report is that all treatments introduced during the last few decades maintain their value, and that none of them can be replaced entirely by any of the subsequent discoveries in psychiatric therapy.
ReSUllle
Un expose sur les traitements somatiques de la depression qui exclut la pharmacotherapie, ne peut cependant pas passer totalement sous silence les medicaments recents, car leur introduction a transforrne et limite les indications des autres methodes. Tant que nous navons eu a disposition que des substances neuroplegi. ques, ou "tranquillisants", nos espoirs d'en finir avec les traitements par le choc, extrernement impopulaires, ou avec les methodes chirurgicales, se sont montres prematures. C'etait le cas en particulier pour ce qui concerne le syndrome depressif, L'entree en scene des medicaments antidepressifs a eu pour consequence de modifier les applications des anciens precedes, en particulier de l' electrochoc. Actuellement encore ce dernier, en tant que methode la plus sure et la plus rapide de traitement des syndromes depressifs graves, est le moyen le plus generalement employe. L'efficacite de cette therapeutique, ainsi que la con fiance qu'elle inspire, varient cependant avec les divers types de depression. L'auteur traite en particulier des diverses categories de patients. La premiere partie de son travail, et la plus etendue, concerne les indications et les resultats de l'electrochoc. Un expose plus bref concerne la psychochirurgie et quelques autres methodes.
Dans les psychoses depressives, le danger de suicide constitue l'indication la plus imperative pour l'institution immediate d'un electrochoc. Les resultats en sont aussi sfirs dans les depressions rnaniaco-depressives ou involutives (qu'elles soient accornpagnees d'inhibition ou dagitation), que dans les depressions seniles, Ils sont presque aussi favorables dans bon nombre de depressions psychoreactives ou psychonevrotiques, celles-ci etant souvent des psychoses affectives accelerees par un stress emotif ou survenant chez des patients porteurs d'une nevrose preexistante, mais non apparentee.
Les resultats de l'electrochoc sont beaucoup moins convaincants dans les syndromes depressifs accompagnant les psychoses schizophreniques et dans les psychoses involutives comportant un melange de symptomes depressifs et paranoides. De merne, les syndromes depressifs des psychoses organiques sont susceptibles de reagir aI'elecrrochoc, mais ades degres divers. Les depressions chroniques qui debutent ala periode involutive et qui sont caracterisees par une atteinte depressive plus superficielle, ainsi que par des idees de ressentiment plutot que d'auto-accusation, de l'hypocondrie et d'autres symptomes atypiques, semblent former un groupe a part. Ces patients reagissent aI'electrcchoc, mais temporairement et sans effet durable. L'entiere disparition des symptornes, si frappante dans d'autres depressions, ri'a pas lieu chez eux, et le malade voit son etat empirer anouveau progressivement apres un certain laps de temps. C'est dans ce groupe qu'il y a lieu d'essayer la therapeutique medicamenteuse, et cela d'autant plus que ces sujets presentent moins de risques au point de vue du suicide.
Quelques remarques de l'auteur concernent les syndromes depressifs au cours d' affections organiques du systeme nerveux. La psychochirurgie est examinee sous l'angle de sa capacite d' ameliorer une depression grave, et des cas de suicide malgre cette intervention sont rapportes. Cependant les psychoses chroniques de l'~ge avarice demeurent parmi les meilleures indications pour le traitement chirurgical. L'auteur mentionne enfin quelques autres traitements organiques des etats depressifs, Discussion* GEORGES SCHNEIDER** Vol. 4,1959 Calling on his long experience in the field of therapy, Dr. Kalinowsky has drawn for us a clear picture of what physical treatments may achieve, but he has been equally eloquent as to their limitations. Not contenting himself with setting forth the historical merits of electro-shock therapy (ECT), he has reviewed the whole problem of indications in the light of recently discovered therapeutic methods. He certainly deserves our congratulations for having kept an open mind while resisting the attraction of novelty and taking great care to state the reasons for his preferences.
The main arguments presented by Dr. Kalinowsky concern electroplexy. To his mind this method appears to be the most reliable and above all the swiftest means by which to treat simple depressive states, whether of the manic-depressive, cyclothymic, involutional, arteriosclerotic or senile type. ECT fails more often in complex or long-lasting affective psychoses, an indication that they fall within the framework of schizophrenias. In respect of the former category, Dr. Kalinowsky claims that ECT has a specific effect. For the latter category, its action is simply symptomatic; once the depressive affect has been overcome, the elements of the basic syndrome become perceptible.
After listening to those speakers who reported on their experience with Tofranil, I am impressed by the fact that the list of their successes and their failures has very much the same order as with ECT. At the head of the list we always find pure endogenous depressions in which the whole psychopathologic symptomatology has its origin in a disturbance of mood.
Dr. Kalinowsky's preference goes to electroplexy because of its capacity to check the development of the depressive attack in the least possible time. What seems important here is to know whether the speaker has not observed just as rapid an effect with Tofranil. He admits that this drug may bring about a mood reversal towards hypomania, as does a series of electroshocks. We ourselves have certainly recorded results of this sort. Yet Dr. Kalinowsky suggests that the action of Tofranil is purely symptomatic, on the grounds that a maintenance dosage is required for a period at least as long as that of the preceding untreated depressive attack. Admittedly such maintenance therapy has become normal practice even when the symptoms of depression have disappeared. But is it not equally true that there continue to be mood swings after ECT instead of complete remission?
For my part I see no qualitative difference between ECT and Tofranil in respect of therapeutic activity as it has been described here. The observation of over 200 cases in the Psychiatric Clinic of the University of Lausanne certainly does not indicate any clear-cut difference. Patients previously treated with ECT come out of their depressive attacks under Tofranil therapy in very much the same way. Generally speaking, the remission is more gradual, but in contrast to our findings with ECT, we have observed no sudden mood reversal immediately followed by a relapse.
In any case, the most useful comparison here can only be with cases of depression recurring more than three times. Dr. Kielholz has shown that the therapeutic response decreases after this, and that mood reversal is then less easily obtained. Indeed among the cases which showed good response to Tofranil but were no longer cured by or responsive to ECT, we find those patients who have very frequent attacks. These results are best illustrated by profiles such as those shown to us by Dr. Freyhan.
Dr. Kalinowsky has shown clearly that ECT is unable to prevent the recurrence of endogenous depressions, that is, to act upon the process itself. However, he quoted a few instances of attempts in this direction in the form of monthly electroshocks. Similar experiments have been done with Tofranil which, especially in this direction, seem to us to be of more value. I was particularly struck by this during our clinical tests. So far we have been successful in only three cases, maintained under continuous small doses, in bringing about a change in the periodicity of attacks in patients who have suffered from depression recurring at very short intervals. We are therefore still far from achieving protective effects comparable to those of anti-epileptic drugs.
What seems to be the crucial point in Dr. Kalinowsky's paper on ECT is his marked tendency to limit the number of shocks. He thus makes no attempt to force results by a cumulative effect, except in cases of atypical depression. Nowhere is it so important to keep dosage low or so necessary to watch closely the reaction to the treatment. Professor Steck and I decided to abandon ECT as soon as we started experimenting with'Tofranil, and only once in the ensuing 22 months did we find it necessary ·to resort to it. We made this decision because we wished to gain experience with a single drug over a fairly long period. It was also inspired, however, by the observation that many depressions occurring before the age of 40 are associated with bioelectric changes and that pathologic changes in the brain are by no means rare at the involutional age. We think this decision will bear fruit since it encourages a more searching diagnosis in place of merely classifying such cases as involutional melancholias. What dictates special caution, however, is the fact that depressed patients are especially sensitive to psycho-organic disorders, no matter how mild. These psychic changes remain while improved techniques have limited to a considerable degree other somatic risks involved in electroplexy.
The neuropsychic complications in Tofranil therapy should not be ignored. Convulsions, dreaming and mental confusion have been observed. In one case, an epileptic fit led us to make EEG studies which revealed an epileptogenic activity of centro-encephalic type. This patient, a woman, was later to show a typically frontal mood reversal after gas encephalography.
In this connection mention should be made of the role played by encephala-pneuma-therapy in the French school. This method is indicated particularly in cases of lingering or recurring melancholia. We mention this only for the purpose of stressing the variety of means used to set off a biological reaction at the level of the processes which regulate the vegetative activities. In this respect pneumoshock should *Translation. ••Associate Professor of Psychiatry, University of Lausanne Psychiatric Clinic, Lausanne, Switzerland. be more selective than electroshock. Unfortunately the selective effect in practice does not come up to theoretical expectations. The neuropathologist Schaltenbrand has compared electroshock to firing buckshot at the grey nuclei: The impacts are numerous but do not always reach their targets. Other types of biological shock -electro-narcosis, acetylcholine shock and others -have been recognized as having little effect on endogenous depressions. These methods fail to produce psycho-organic perturbations or electric changes comparable to those caused by more intense shock treatments. There are therefore strong reasons for thinking that electroshock cannot be effective without causing organic changes more profound than is generally recognized.
Is any form of psychosurgery effective in depression? Dr. Kalinowsky has referred to investigations in Great Britain which show that depressions of a hypochondriac, chronic and simple endogenous type have been improved by leucotomy. It would be interesting to know which type of surgery has been found most effective.
Developments in the field of brain surgery show that the controversy has not been settled between selective methods and more extensive interventions. In my opinion, these methods should be rejected now that other solutions look so promising.
General discussion from the floor (summarized) In the general discussion that followed, Dr. Kalinowsky was asked to comment on observations of transient brain changes, first observable after 4-6 ECT's. The EEG usually showed changes at this point and memory changes were often seen. Recently such a change was observed at once after ECT in a patient who had been on Tofranil. Is it possible that the drug permitted a more rapid appearance of the EEG changes?
It was suggested that since psychotherapy is a high-prestige treatment, no psychiatrist likes to admit that he does not employ it liberally. In fact, however, patients on ECT receive milieu therapy rather than depth or free association psychotherapy.
Another question involved the best procedure to handle anxiety and fear of ECT in patients. The use of curare in this regard was mentioned. The length of the post-ECT amnesic syndrome was also queried. The usefulness of an irreversible treatment such as lobotomy in depression, in view of pharmacological advances, was questioned. The discussant preferred less drastic methods at present.
One discussant commented on depression in old age, and the treatability of many members of this group. North American and British statistics in this regard were compared.
Another discussant asked a theroretical question on the mode of action of convulsive therapy. He wondered what Dr. Kalinowsky thought of the specific denial hypothesis put forward by Weinstein, Kahn and Simm in 1952. Dr. Kalinowsky was further asked at what point he felt ECT should be stopped in regressive ECT.
Another discussant expressed the opinion that although ECT will eliminate any depression it is not indicated in all depressions. ECT may shorten length of illness in a general hospital, but will not work in 50 per cent of the cases where it is given, and when used with success patients remain ill for at least 4 weeks. Tofranil is often more prompt, and is especially advantageous because it does not produce amnesia. This is an important consideration in patients whose occupation is intellectually demanding. Moreover, there is a link in terms of the continuity of human experience, especially with the doctor, when the patient is on the drug, but this continuity is lost with ECT. The speaker wondered if those who emphasized the safety of ECT would use it on themselves as readily as they would the drug.
Comments on leucotomy were then made. A discussant wondered why this treatment is largely abandoned in America while the results in English patients have been extraordinarily satisfactory. He emphasized that he was not speaking of total cut leucotomy, but of the modified procedure. Between eighty and ninety per cent of the depressed cases have done well on this treatment, especially those with tension depressions and obsessive-compulsive features.
One speaker commented that most patients who rejected shock treatment did so as a rationalized fear of their melancholic illness, which was then projected onto the ECT. Because of this, the manner in which a patient is referred to a hospital is of importance. It is also important that the patient be calm and that he walk rather than be carried to and from treatment. He felt that Tofranil should be tried first; if it does not work, then ECT should be given, then both together.
Dr. Kalinowsky replied to the questions: He had never favored the theory mentioned in connection with brain changes after ECT. Best ECT results occurred after one or two treatments, and prior to really obvious brain changes. He agreed that EEG changes are often present, but questioned their significance.
In reply to the question about the specific denial theory of ECT effect, he would speculate that the functional psychoses probably involve hypothalamic functioning at some level, and that with ECT something occurs in this area. He is reasonably certain that the ordinary EEG cannot measure the changes that may occur.
In handling the fears of patients in regard to ECT, sedation techniques can be helpful. It is important to distinguish between the patient's feeling of apprehension on waking and his fear of amnesia and disorientation. In reply to the question of when to stop regressive ECT, he favors continuing until urinary incontinence and loss of sense of identity appear. Lastly, he feels that all treatments should be used selectively.
